Skip to content

Impact of Canine Mediation Practice in Psychomotor Therapy on Improving the Quality of Life in Adult Epileptic Patients.

Impact of Canine Mediation Practice in Psychomotor Therapy on Improving the Quality of Life in Adult Epileptic Patients.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06898749
Acronym
MCP-Epi
Enrollment
76
Registered
2025-03-27
Start date
2026-01-31
Completion date
2029-06-30
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

In addition to the search for new pharmaceutical or surgical solutions that could improve the therapeutic management of epileptic individuals, it is interesting to ask whether other complementary approaches, such as canine mediation in psychomotor therapy, could enhance the quality of life in this population. However, there is currently no evidence indicating that exposure to animals through mediation sessions would be beneficial for epileptic individuals, particularly regarding their quality of life, anxiety, emotional management, or cognition (such as social cognition). In the absence of current data in this population, it seems pertinent to study the impact of this practice on people with epilepsy. Furthermore, beyond quality of life, it would be valuable to examine whether it also influences anxiety or the frequency of seizures in individuals with epilepsy (a phenomenon reported for epileptic individuals living with a pet dog or a service dog). Canine mediation could help better manage and regulate the emotions of epileptic individuals, as well as improve their self-esteem.

Interventions

OTHERcanine mediation

Animal mediation consists of bringing an animal into contact with a specific audience to improve the mental or physical health of a person. The dog and beneficiaries interact through various activities, in which the animal participates, offered during the sessions. The dog plays a particularly important role as a mediator through the bonds it forms with the human, as well as a non-judgmental partner in interaction. The canine educator will be accompanied by a healthcare professional during interventions. The sessions are organized based on the expertise and suggestions of both professions (canine educator and psychomotor therapist). The canine educator will be a state-certified professional educator with a specialization in animal mediation. The dog used is trained by the educator, with two types of learning being worked on: emotions and commands on cue.

standard sessions of psychomotor therapy

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Person aged ≥ 18 years * Presenting pharmacoresistant epilepsy according to the criteria of the International League Against Epilepsy * Requiring psychomotor therapy sessions for one of the following indications: Difficult emotional and relational management And/or global motor difficulties And/or body schema organization disorder And/or temporo-spatial disorder * Explicit consent or no opposition to participation in the study by the patient and/or their legal representative or guardian * Image rights consented by the patient and their legal representative or guardian, if applicable * Hospitalization or residence at the Teppe Institute or at the FAM (Foyer d'Accueil Médicalisé) des 4 Jardins planned for at least 3 months * Affiliated with or a beneficiary of a social security scheme

Exclusion criteria

* Fear or phobia of dogs * Epileptic person benefiting from a legal protection measure other than guardianship or curatorship * Person with insufficient cognitive abilities to respond to the questionnaires * Pregnant or breastfeeding woman

Design outcomes

Primary

MeasureTime frameDescription
Improvement of quality of lifeDay 0 and Day 7 after the end of the 10 sessionsIncrease in the Quality of Life in Epilepsy Inventory-31 (QOLIE-31) score of at least 5 points between inclusion and one week after the completion of the 10 sessions. The score of the QOLIE-31 (Quality of Life in Epilepsy Inventory-31) ranges from 0 to 100. A score of 0 represents the worst possible quality of life, while a score of 100 represents the best possible quality of life.

Contacts

Primary ContactAmelie Yavchitz
ayavchitz@for.paris+33148036454

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026